HSBC initiated coverage on shares of Haleon (LON:HLN – Free Report) in a research note published on Thursday, MarketBeat reports. The brokerage issued a buy rating on the stock.
Separately, Barclays decreased their price objective on shares of Haleon from GBX 390 ($4.85) to GBX 383 ($4.77) and set an overweight rating for the company in a research note on Tuesday, April 9th.
Haleon Stock Up 1.0 %
Haleon Increases Dividend
The business also recently declared a dividend, which will be paid on Thursday, May 16th. Stockholders of record on Thursday, March 14th will be paid a dividend of GBX 4.20 ($0.05) per share. This represents a dividend yield of 1.34%. The ex-dividend date is Thursday, March 14th. This is an increase from Haleon’s previous dividend of $1.80. Haleon’s payout ratio is currently 5,454.55%.
Insider Activity
In other news, insider Tobias Hestler sold 23,564 shares of Haleon stock in a transaction that occurred on Friday, March 1st. The shares were sold at an average price of GBX 329 ($4.10), for a total transaction of £77,525.56 ($96,508.85). Insiders own 22.53% of the company’s stock.
Haleon Company Profile
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.
Recommended Stories
- Five stocks we like better than Haleon
- What Investors Need to Know to Beat the Market
- Comprehensive PepsiCo Stock Analysis
- What is a Low P/E Ratio and What Does it Tell Investors?
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- What is the S&P/TSX Index?
- Bear Market Funds to Watch This Year
Receive News & Ratings for Haleon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Haleon and related companies with MarketBeat.com's FREE daily email newsletter.